Delivery Order SPE2DB22D1017-SPE2DB24FF7EM
Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,736.86 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,127.09 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of NURTEC ODT 75 MG TABLET 8S pharmaceutical products. The $4,739.97 delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of June 21, 2022. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC enables the company to efficiently...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $24,902.60 for the supply of NURTEC ODT 75 MG TABLET 8S medical products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of February 1, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,662.47 Firm Fixed Price Delivery Order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,638.33 Firm Fixed Price Delivery Order is for NURTEC ODT 75 MG TABLET 8S, and has an ultimate completion date of January 9, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $3,712.23 for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award has an ultimate completion date of February 28, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,861.12 firm fixed-price delivery order covers the supply of NURTEC ODT 75 mg tablets to the DLA. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The $37,740.64 delivery order contract is a firm fixed-price agreement with a completion date of December 16, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,598.86, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of January 19, 2024 and is a Firm Fixed Price Delivery Order. The contract was awarded on January 18, 2024 and does not have a set-aside designation, indicating it was competed...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF7EMDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NURTEC ODT 75 MG TABLET 8S prescription medication. The $11,212.65 firm fixed price delivery order contract has a completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations.
Generated 5/16/25, 12:25 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 5/6/24 |